Partnering for enhanced digital surveillance of influenza-like disease and the effect of antivirals and vaccines (PEDSIDEA).
Barbara A RathHelena C MaltezouVassiliki PapaevangelouMaria-Alexandra Papagrigoriou-TheodoridouMaren AlchikhPuja MylesBrunhilde Schweigernull nullPublished in: Influenza and other respiratory viruses (2019)
The Risk-adjusted ViVI Score enables a precision medicine approach to managing ILI in multicentre settings. Using mobile applications, severity data will be obtained in real time with important implications for the evaluation of antiviral/vaccine use.